Latest Interviews
Showing 211–225 of 1,615 transcripts.
Clear all filters- Milken Institute55 min
2025 Milken Institute Best Performing Cities Overview
Maggie Switek, Janet Cowell, Ben Nadolski
The Milken Institute ranked Raleigh, North Carolina, and Ogden-Clearfield, Utah, as the top two large U.S. metropolitan areas by balancing labor market data with community well-being metrics. Raleigh achieved this standing through a diverse economy anchored by life sciences and higher education, alongside strategic investments in green infrastructure and inclusive workforce training. Meanwhile, Ogden-Clearfield leveraged its defense and aerospace base, a culture of shared responsibility, and an equitable income distribution model to secure the number two spot while preparing for the 2034 Winter Olympics.
- Milken Institute1h 1m
The Emerging World of Opportunities: Insights from MI's Global Opportunity Index | Global Conference
Carole Biau, Jarred Glansbeek, Richard Jadulan, Leticia Jáuregui Casanueva, Toyin Sanni, Carol Beo, Jared Glanzbeck
The Milken Institute Global Opportunity Index panel evaluated investment landscapes across Sub-Saharan Africa, Latin America, and Asia, highlighting specific regional drivers such as Nigeria's administrative reforms, Mexico's nearshoring potential, and the Philippines' regulatory liberalization. Key speakers Jared Glanzbeck, Dr. Toyin Sani, and Leticia Haureyi-Casanueva emphasized that undervalued emerging markets offer significant equity entry points when investors overcome perception gaps through local partnerships and targeted focus on gender diversity and climate resilience. The discussion concluded that strategic capital allocation into human capital and sustainable infrastructure remains critical for capturing the substantial foreign direct investment inflows correlated with improved institutional frameworks.
- Milken Institute56 min
Inclusive Capitalism: Unleashing Growth in the Global Economy | Global Conference 2024
Troy Duffie, Nisha Biswal, Roger Ferguson, Carla Harris, Martin Nesbitt
This event convened economic and financial leaders to analyze the U.S. job market, evolving inflation dynamics, and the strategic expansion of private credit and development finance in response to global supply chain shifts. Panelists redefined investment frameworks through "Capitalism 3.0," integrating ESG metrics and diversity initiatives into core risk management while addressing the Series A funding gap for entrepreneurs of color. Key outcomes included the U.S. Development Finance Corporation's doubled mandate to $60 billion and the launch of Morgan Stanley's Next Level Fund, which pairs capital with operational expertise to support inclusive growth and stable returns.
- Milken Institute51 min
Credit Investors Taking the Reins | Middle East and Africa Summit 2024
Michael Piwowar, Sandeep Chandak, Michael Gross, Zia Uddin, Orla Walsh, Mike Pivovar
A panel of industry leaders outlined the divergent trajectories of global private credit markets, noting Asia's rapid expansion into a mature source of alpha while the U.S. market faces yield compression and systemic stress from high leverage in the upper-middle sector. Speakers detailed strategic shifts toward labor-intensive origination, specialized financing for infrastructure gaps, and the regulatory necessity of robust legal frameworks to protect investor interests. The discussion concluded that future success depends on diversified, multi-strategy approaches capable of navigating retailization risks and generating equity-like returns as the industry transitions from a double-digit return era to a more normalized competitive landscape.
- Milken Institute48 min
The Evolving Landscape of Private Markets | Middle East and Africa Summit 2024
Laura Merlini, Lauren Goodwin, Klaus Hommels, Scott Spielvogel, David Steinbach, Andrew Weinberg
The event examines how shifting macroeconomic trends, including lower interest rates and the $90 trillion generational wealth transfer, are driving capital into private markets while redefining exit strategies and liquidity structures. Speakers detailed critical convergence points where defense tech, AI implementation, and infrastructure real estate intersect with evolving regulatory frameworks in Europe and the US. These discussions project a resilient 2025 outlook where public and private market mechanisms merge to support middle-market growth and operational innovation.
- Milken Institute53 min
Asset Management: Vying for the Competitive Edge | Middle East and Africa Summit 2024
Michael Piwowar, Todd Boehly, Lawrence Golub, Martin Horne, Camilla Languille, Stephanie Rader, Mike Pivovar
Leading global investors, including Mubadala, Eldridge, Golub Capital, and Goldman Sachs Asset Management, discussed strategies for navigating a shifting landscape characterized by the convergence of artificial intelligence and energy infrastructure needs. The panel highlighted specific tactical shifts such as Mubadala's launch of the MGX AI fund, Eldridge's opportunistic crisis lending, and the region's urgent demand for private credit to support Saudi Vision 2030. Additionally, participants analyzed geopolitical diversification away from China toward India and emphasized the Middle East's role as a critical hub for attracting global AI talent and scaling sustainable technology investments.
- Milken Institute54 min
Global Cities in a New Light | Middle East and Africa Summit 2024
Natasha Turak, Eric Garcetti, Goodwin Gaw, Nikhil Goel, Yasseen Mansour
Speakers from Archer Aviation, global city leaders, and real estate investors discussed strategies to overcome urban congestion through electric air taxis, high-density housing reforms, and sustainable infrastructure projects like Badia in Egypt. Key figures highlighted the critical need to balance ambitious greenfield experiments such as NEOM with practical financial viability, while advocating for regulatory pathways that bypass entrenched NIMBYism. The dialogue concluded with a consensus that successful future cities require integrated planning combining vertical mixed-income development, autonomous transport corridors, and organic growth models to ensure long-term livability and economic sustainability.
- Milken Institute1h 14m
Navigating a Changing Global Economy | Middle East and Africa Summit 2024
Laura Deal Lacey, Michael Milken, His Royal Highness Prince Turki Al Faisal Al Saud, Makhtar Diop, Mohamed Mansour, Alan Schwartz, Prince Turki Al Faisal Al Saud
Held in Abu Dhabi in December 2024, the 6th Annual Middle East and Africa Summit convened global leaders from the Milken Institute, the International Finance Corporation, and the Mansour Group to mobilize capital toward healthcare, economic development, and environmental sustainability. The event highlighted a strategic pivot where emerging markets are transforming from passive capital providers into technology hubs capable of bridging the gap between the aging Global North and Africa's young, growing workforce. Participants addressed critical investment barriers such as regulatory uncertainty and currency mismatches by proposing blended finance models and de-risking strategies to unlock trillions of dollars in private and philanthropic resources.
- Milken Institute1h 1m
Decoding Disease: Can Genetics Unlock New Interventions? | Future of Health Summit 2024
Conor Hale, Colleen Campbell, Lon Cardon, Bernard Kwabi-Addo, Benjamin Neale
Experts highlight that while genomic knowledge has expanded to 12,000 identified variants, translating these discoveries into clinical care remains hindered by insurance barriers, provider literacy gaps, and biased data representation. To overcome these bottlenecks, the field is increasingly leveraging artificial intelligence for tumor heterogeneity analysis and shifting toward deconstructing common diseases into rare, monogenic subsets for targeted therapies. With sequencing costs dropping to roughly $200, stakeholders anticipate widespread population screening programs and systematic variant analysis across human diseases becoming feasible within the next decade.
- Milken Institute53 min
Health Care of the Future | Future of Health Summit 2024
Michael Milken, Alex Azar, Buddy Carter, Diana DeGette, Renee Wegrzyn
The event detailed how ARPA-H and legislative initiatives like "Cures 2.0" are addressing systemic healthcare challenges by funding high-risk biomedical innovations and ensuring pharmaceutical independence. Key figures including Rep. Diana DeGette and Rep. Chris Carter highlighted strategies to reform Medicare Advantage payment models and repatriate drug manufacturing to counter supply chain vulnerabilities. The panel concluded with a call for increased federal investment in translational science and a broader call for business leaders to enter government to sustain the pace of medical breakthroughs.
- Milken Institute1h 11m
Global Collaboration to Eradicate Women’s Cancers | Future of Health Summit 2024
Alice Park, Usman Malami Aliyu, Danielle Carnival, Dave Fredrickson, Roberta Lipson, Gemma Peters
Global cancer leaders convened to address the projected doubling of incidence in low- and middle-income countries by implementing diverse strategies ranging from Nigeria's mobile screening vans and mobile PCR labs in China to the UK's data-driven risk assessment partnerships. These initiatives prioritize overcoming structural inequities in treatment access, financial barriers, and clinical trial participation through innovations like AI-driven imaging, drug repurposing, and targeted care navigation programs. Ultimately, the consensus emphasizes that sustainable national cancer control plans must integrate geopolitical cooperation and equity-first designs to prevent the fragmentation of global research and ensure effective prevention for the most vulnerable populations.
- Milken Institute58 min
Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024
Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels
This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.
- All-In Podcast1h 10m
DOGE unveils a roadmap, Unlocking GDP Growth, WW3 escalation, Fat cell memory
Chamath, Friedberg, Jason Calacanis, David Sacks
Elon Musk and Vivek Ramaswamy's Department of Government Efficiency plans to eliminate $500 billion in unauthorized federal spending over an 18-month period by leveraging recent Supreme Court rulings to bypass traditional legislative approval processes. The initiative targets regulatory rollbacks through executive audits and temporary payment suspensions while facing anticipated legal challenges from entrenched bureaucratic interests and internal Republican resistance to deficit reduction. Concurrently, the discussion highlights global security risks regarding Western missile capabilities in the Ukraine-Russia conflict and presents scientific breakthroughs in epigenetics that explain persistent obesity mechanisms despite weight loss.
- Milken Institute1h 0m
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.
- Milken Institute54 min
Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024
Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun
As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.